Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life
- PMID: 30254486
- PMCID: PMC6140696
- DOI: 10.2147/JPR.S159729
Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life
Erratum in
-
Erratum: Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life [Corrigendum].J Pain Res. 2018 Oct 17;11:2397. doi: 10.2147/JPR.S189356. eCollection 2018. J Pain Res. 2018. PMID: 30425552 Free PMC article.
Abstract
Background: The objective of the study was to estimate the prevalence of pure central neuropathic pain (CNP) and peripheral neuropathic pain (PNP) among patients attending pain clinics in Spain. The study also aimed to analyze factors associated with pain intensity and quality of life (QoL).
Methods: A cross-sectional study was performed including 53 patients with pure CNP and 281 with pure PNP attending in 104 pain clinics in Spain. The revised grading system proposed in 2008 to determine a definite, probable or possible diagnosis of NP was used. Pain features, psychological variables and QoL were assessed. Descriptive, bivariate and multivariate analyses were performed.
Results: The prevalence of pure CNP and PNP amongst neuropathic pain patients was 2.4% (95% CI: 1.7;3.1) and 12.9% (95% CI: 1.5;14.3), respectively. Comorbid anxiety, depression or sleep disorders were high in both groups, but higher in CNP patients (51.1%, 71.4%, respectively). Pain intensity in PNP patients was associated with the presence of depression and sleep disturbances. However, in CNP patients, it was related with pain in the lower limbs. The impairment of QoL was greater in CNP patients than in PNP patients; pain location, presence of depression and sleep disturbance were the factors that most negatively affected QoL. Among PNP patients, women and those with higher pain intensity had worse QoL.
Conclusion: Pain intensity and QoL are affected by different factors in patients suffering from CNP or PNP. Identifying these factors could serve to guide therapeutic strategies and improve the QoL of patients.
Keywords: central neuropathic pain; pain intensity; peripheral neuropathic pain; quality of life.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Radiation-induced Chronic Pain Plagues Head and Neck Cancer Survivors: A Cross-sectional Analysis From the Cohort in Radiotherapy-related Nervous System Complications.J Pain. 2024 Oct;25(10):104612. doi: 10.1016/j.jpain.2024.104612. Epub 2024 Jun 20. J Pain. 2024. PMID: 38908498
-
Chronic Pain Features Relate to Quality of Life More than Physiopathology: A Cross-Sectional Evaluation in Pain Clinics.Pain Pract. 2017 Sep;17(7):866-878. doi: 10.1111/papr.12533. Epub 2017 Feb 25. Pain Pract. 2017. PMID: 27782366
-
High prevalence of confirmed, but also of potential and believed, neuropathic pain in pain clinics.Eur J Pain. 2013 Mar;17(3):347-56. doi: 10.1002/j.1532-2149.2012.00204.x. Epub 2012 Aug 24. Eur J Pain. 2013. PMID: 22927200
-
Transcutaneous Electrical Nerve Stimulation in Relieving Neuropathic Pain: Basic Mechanisms and Clinical Applications.Curr Pain Headache Rep. 2020 Feb 18;24(4):14. doi: 10.1007/s11916-020-0846-1. Curr Pain Headache Rep. 2020. PMID: 32072323 Review.
-
Pain responsiveness to opioids: central versus peripheral neuropathic pain.J Opioid Manag. 2011 Sep-Oct;7(5):391-400. doi: 10.5055/jom.2011.0080. J Opioid Manag. 2011. PMID: 22165038 Review.
Cited by
-
Pain rates in general population for the period 1991-2015 and 10-years prediction: results from a multi-continent age-period-cohort analysis.J Headache Pain. 2020 May 13;21(1):52. doi: 10.1186/s10194-020-01108-3. J Headache Pain. 2020. PMID: 32404046 Free PMC article.
-
SIRT1 Decreases Emotional Pain Vulnerability with Associated CaMKIIα Deacetylation in Central Amygdala.J Neurosci. 2020 Mar 11;40(11):2332-2342. doi: 10.1523/JNEUROSCI.1259-19.2020. Epub 2020 Jan 31. J Neurosci. 2020. PMID: 32005763 Free PMC article.
-
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain.J Headache Pain. 2022 Aug 16;23(1):102. doi: 10.1186/s10194-022-01475-z. J Headache Pain. 2022. PMID: 35974316 Free PMC article.
-
Noncoding RNAs: Novel Targets for Opioid Tolerance.Curr Neuropharmacol. 2023;21(5):1202-1213. doi: 10.2174/1570159X21666221129122932. Curr Neuropharmacol. 2023. PMID: 36453497 Free PMC article. Review.
-
Anxiolytic effects of the novel α2δ ligand mirogabalin in a rat model of chronic constriction injury, an experimental model of neuropathic pain.Psychopharmacology (Berl). 2020 Jan;237(1):189-197. doi: 10.1007/s00213-019-05356-3. Epub 2019 Sep 12. Psychopharmacology (Berl). 2020. PMID: 31515584
References
-
- Pérez C, Ribera MV, Gálvez R, et al. High prevalence of confirmed, but also of potential and believed, neuropathic pain in pain clinics. Eur J Pain. 2013;17(3):347–356. - PubMed
-
- Cohen SP, Mao J. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014;348:f7656. - PubMed
-
- Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149(2):338–344. - PubMed
-
- Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain. 2011;152(12):2836–2843. - PubMed
-
- Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380–387. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous